BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25877777)

  • 21. Proceedings: Carcinogenic and mutagenic activity of chromium containing materials.
    Levy LS; Venitt S
    Br J Cancer; 1975 Aug; 32(2):254-5. PubMed ID: 1212393
    [No Abstract]   [Full Text] [Related]  

  • 22. [Green tea and its role on chemoprevention in vivo of genotoxic damage induced by carcinogenic metals (chromium [VI])].
    García-Rodríguez MC; Vilches-Larrea RE; Nicolás-Méndez T; Altamirano-Lozano MA
    Nutr Hosp; 2012; 27(4):1204-12. PubMed ID: 23165563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of nonmutagenic Cr(III)-DNA interactions.
    Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
    Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromium hexavalent compounds.
    Rep Carcinog; 2004; 11():III63-6. PubMed ID: 21089834
    [No Abstract]   [Full Text] [Related]  

  • 25. Chromium in drinking water: sources, metabolism, and cancer risks.
    Zhitkovich A
    Chem Res Toxicol; 2011 Oct; 24(10):1617-29. PubMed ID: 21766833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of micronucleus tests for screening mutagens and carcinogens].
    Sycheva LP; Zhukov VS
    Vestn Ross Akad Med Nauk; 1997; (7):14-8. PubMed ID: 9324374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clastogenicity and mutagenicity of hexavalent chromium in lacZ transgenic mice.
    Itoh S; Shimada H
    Toxicol Lett; 1997 May; 91(3):229-33. PubMed ID: 9217243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
    McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
    Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic, mutagenic and clastogenic effects of industrial chromium compounds.
    Venier P; Montaldi A; Majone F; Bianchi V; Levis AG
    Carcinogenesis; 1982; 3(11):1331-8. PubMed ID: 6758977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromium-induced genotoxicity and interference in human lymphoblastoid cell (TK6) repair processes.
    El-Yamani N; Zúñiga L; Stoyanova E; Creus A; Marcos R
    J Toxicol Environ Health A; 2011; 74(15-16):1030-9. PubMed ID: 21707427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenic Effects of Potassium Dichromate as Evaluated by Means of Animal and Plant Bioindicators.
    Rocha C; Cardoso P; Cunha L; Gomes C; Júnior RR; Pinheiro RH; Costa MH; Burbano R
    In Vivo; 2015; 29(6):729-35. PubMed ID: 26546529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micronucleus induction by chromium and selenium, and suppression by metallothionein inducer.
    Itoh S; Shimada H
    Mutat Res; 1996 Apr; 367(4):233-6. PubMed ID: 8628330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High mobility group proteins 1 and 2 recognize chromium-damaged DNA.
    Wang JF; Bashir M; Engelsberg BN; Witmer C; Rozmiarek H; Billings PC
    Carcinogenesis; 1997 Feb; 18(2):371-5. PubMed ID: 9054631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromium (III) and chromium (VI) as important players in the induction of genotoxicity - current view.
    Sawicka E; Jurkowska K; Piwowar A
    Ann Agric Environ Med; 2021 Mar; 28(1):1-10. PubMed ID: 33775062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring relationships between mutagenic and carcinogenic potencies.
    Piegorsch WW; Hoel DG
    Mutat Res; 1988 Sep; 196(2):161-75. PubMed ID: 3419441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair.
    Reynolds M; Stoddard L; Bespalov I; Zhitkovich A
    Nucleic Acids Res; 2007; 35(2):465-76. PubMed ID: 17169990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
    Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotoxic effects of chromium oxide nanoparticles and microparticles in Wistar rats after 28 days of repeated oral exposure.
    Singh SP; Chinde S; Kamal SS; Rahman MF; Mahboob M; Grover P
    Environ Sci Pollut Res Int; 2016 Feb; 23(4):3914-24. PubMed ID: 26503004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms.
    Beyersmann D; Hartwig A
    Arch Toxicol; 2008 Aug; 82(8):493-512. PubMed ID: 18496671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.